93 related articles for article (PubMed ID: 38473249)
1. Targeting the PI3K/AKT/mTOR pathway in triple-negative breast cancer: a review.
Costa RLB; Han HS; Gradishar WJ
Breast Cancer Res Treat; 2018 Jun; 169(3):397-406. PubMed ID: 29417298
[TBL] [Abstract][Full Text] [Related]
2. Myricetin-induced apoptosis in triple-negative breast cancer cells through inhibition of the PI3K/Akt/mTOR pathway.
Sharma P; Khan MA; Najmi AK; Chaturvedi S; Akhtar M
Med Oncol; 2022 Oct; 39(12):248. PubMed ID: 36209343
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of TNBC Cell Growth by Paroxetine: Induction of Apoptosis and Blockage of Autophagy Flux.
Huang Q; Wu M; Pu Y; Zhou J; Zhang Y; Li R; Xia Y; Zhang Y; Ma Y
Cancers (Basel); 2024 Feb; 16(5):. PubMed ID: 38473249
[TBL] [Abstract][Full Text] [Related]
4. Pimavanserin tartrate induces apoptosis and cytoprotective autophagy and synergizes with chemotherapy on triple negative breast cancer.
Zhang Y; Huang Q; Xu Q; Jia C; Xia Y
Biomed Pharmacother; 2023 Dec; 168():115665. PubMed ID: 37832400
[TBL] [Abstract][Full Text] [Related]
5. Radix Tetrastigma Extracts Enhance the Chemosensitivity in Triple-Negative Breast Cancer Via Inhibiting PI3K/Akt/mTOR-Mediated Autophagy.
Zhang S; Cui T; Duan Y; Zhang H; Wang B; Chen H; Ni J; Shen Y; Xiao-Ai Lv
Clin Breast Cancer; 2022 Feb; 22(2):89-97. PubMed ID: 34535390
[TBL] [Abstract][Full Text] [Related]
6. A novel orally available seleno-purine molecule suppresses triple-negative breast cancer cell proliferation and progression to metastasis by inducing cytostatic autophagy.
Chang CH; Bijian K; Wernic D; Su J; da Silva SD; Yu H; Qiu D; Asslan M; Alaoui-Jamali MA
Autophagy; 2019 Aug; 15(8):1376-1390. PubMed ID: 30773992
[TBL] [Abstract][Full Text] [Related]
7. Calycosin inhibits triple-negative breast cancer progression through down-regulation of the novel estrogen receptor-α splice variant ER-α30-mediated PI3K/AKT signaling pathway.
Li Y; Hu S; Chen Y; Zhang X; Gao H; Tian J; Chen J
Phytomedicine; 2023 Sep; 118():154924. PubMed ID: 37393829
[TBL] [Abstract][Full Text] [Related]
8. Fluoxetine Inhibits STAT3-mediated Survival and Invasion of Osteosarcoma Cells.
Chen WT; Tsai YH; Tan P; Hsu FT; Wang HD; Lin WC; Lin FH; Wu CT
Anticancer Res; 2023 Mar; 43(3):1193-1199. PubMed ID: 36854535
[TBL] [Abstract][Full Text] [Related]
9. Reversing T Cell Dysfunction to Boost Glioblastoma Immunotherapy by Paroxetine-Mediated GRK2 Inhibition and Blockade of Multiple Checkpoints through Biomimetic Nanoparticles.
Wang T; Zhang H; Han Y; Zheng Q; Liu H; Han M; Li Z
Adv Sci (Weinh); 2023 Mar; 10(9):e2204961. PubMed ID: 36698265
[TBL] [Abstract][Full Text] [Related]
10. Cancer statistics, 2023.
Siegel RL; Miller KD; Wagle NS; Jemal A
CA Cancer J Clin; 2023 Jan; 73(1):17-48. PubMed ID: 36633525
[TBL] [Abstract][Full Text] [Related]
11. Targeting Necroptosis: A Novel Therapeutic Option for Retinal Degenerative Diseases.
Zhang Q; Hu XM; Zhao WJ; Ban XX; Li Y; Huang YX; Wan H; He Y; Liao LS; Shang L; Jiang B; Qing GP; Xiong K
Int J Biol Sci; 2023; 19(2):658-674. PubMed ID: 36632450
[TBL] [Abstract][Full Text] [Related]
12. Colon tumour cell death causes mTOR dependence by paracrine P2X4 stimulation.
Schmitt M; Ceteci F; Gupta J; Pesic M; Böttger TW; Nicolas AM; Kennel KB; Engel E; Schewe M; Callak Kirisözü A; Petrocelli V; Dabiri Y; Varga J; Ramakrishnan M; Karimova M; Ablasser A; Sato T; Arkan MC; de Sauvage FJ; Greten FR
Nature; 2022 Dec; 612(7939):347-353. PubMed ID: 36385525
[TBL] [Abstract][Full Text] [Related]
13. OSW-1 induces apoptosis and cyto-protective autophagy, and synergizes with chemotherapy on triple negative breast cancer metastasis.
Wu M; Huang Q; Liao M; Wu X; Xi H; Ma H; Li S; Zhang Y; Xia Y
Cell Oncol (Dordr); 2022 Dec; 45(6):1255-1275. PubMed ID: 36155886
[TBL] [Abstract][Full Text] [Related]
14. DNA repair proteins as the targets for paroxetine to induce cytotoxicity in gastric cancer cell AGS.
Liu BH; Yuan TM; Huang CJ; Hsu DT; Chen SW; Hsiao NW; Lin SC; Wu SW; Lin YJ; Chuang SM
Am J Cancer Res; 2022; 12(4):1465-1483. PubMed ID: 35530295
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
